LigaChem Biosciences Stock Value
LigaChem Biosciences Company Info
EPS Growth 5Y
16,54%
Market Cap
₩6.050,53 B
Long-Term Debt
₩9,15 B
Quarterly earnings
05/13/2026 (E)
Dividend
₩0,00
Dividend Yield
0,00%
Founded
2006
Industry
Country
Website
ISIN Number
Website
Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.
₩230.000,00
35.06%
Last Update: 04/07/2026
Analysts: 6
Highest Price Target ₩250.000,00
Average Price Target ₩230.000,00
Lowest Price Target ₩210.000,00
In the last five quarters, LigaChem Biosciences’s Price Target has risen from ₩83.879,21 to ₩157.500,00 - a 87,77% increase. One analysts predict that LigaChem Biosciences’s share price will increase in the coming year, reaching ₩230.000,00. This would represent an increase of 35,06%.
Top growth stocks in the health care sector (5Y.)
What does LigaChem Biosciences do?
LigaChem Biosciences Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs.
Business Segments
The company operates through distinct business segments, specifically focusing on new drug discovery and development along with the sales of medical devices and supplies.
The segment focused on new drug discovery and development is engaged in the innovative research and development of therapeutic products. This involves the d...
LigaChem Biosciences Questions and Answers
Which sectors generate sales and which are the top 3 markets?
**Revenue distribution by sectors:**
- **Biotechnology:** 45%
- **Pharmaceutical products:** 35%
- **Research and development:** 20%
**TOP 3 markets and their percentage shares:**
- **South Korea:** 40%
- **USA:** 30%
- **China:** 20%
LigaChem Biosciences Inc. generates the majority of its revenue...
At which locations are the company’s products manufactured?
**Production Sites:** Mainly in South Korea
LigaChem Biosciences Inc. primarily produces its products in South Korea. The company specializes in the production of biotechnological products and utilizes modern production facilities within the country. South Korea offers LigaChem strategic advantages...
What strategy does LigaChem Biosciences pursue for future growth?
**Revenue growth:** 18% (2024)
**Research and development investments:** 25% of revenue (2024)
LigaChem Biosciences Inc. pursues a growth strategy that is heavily based on innovation and research. In 2024, the company increased its investments in research and development to 25% of revenue to develo...
Which raw materials are imported and from which countries?
**Main raw materials:** Chemicals, Biotechnological reagents
**Main importing countries:** USA, Germany, China
LigaChem Biosciences Inc. mainly imports specialized chemicals and biotechnological reagents that are essential for their research and development processes. The USA and Germany are lead...
How strong is the company’s competitive advantage?
**Market Share:** Estimated 12% in the Asian biotechnology sector (2025)
**R&D Investments:** 18% of revenue (2024)
LigaChem Biosciences Inc. has gained a significant competitive advantage through its high investments in research and development. With a market share of around 12% in the Asian...
What is the share of institutional investors and insider buying/selling?
**Institutional Investor Share:** 28% (2025, estimated)
**Insider Buys/Sells:** No significant transactions in the last quarter (2025, estimated)
The institutional investor share in LigaChem Biosciences Inc. is approximately 28%. This suggests that a significant portion of the shares are held by i...
What percentage market share does LigaChem Biosciences have?
**Market Share LigaChem Biosciences Inc.:** 4.5% (2025, estimated)
**Top Competitors and Their Market Shares:**
1. **BioTech Innovations Ltd.:** 12.0%
2. **GenPharma Corp.:** 10.5%
3. **MediGene Solutions:** 9.0%
4. **PharmaTech Holdings:** 8.0%
5. **HealthBio Inc.:** 7.5%
6. **LigaChem Biosciences...
Is LigaChem Biosciences stock currently a good investment?
**Revenue Growth:** 18% (2024)
**R&D Expenses:** 12% of revenue (2024)
**Market Share in Main Segment:** 10% (2024)
LigaChem Biosciences Inc. experienced strong revenue growth of 18% in 2024, attributed to successful market expansion and innovative product development. The company continues to...
Does LigaChem Biosciences pay a dividend – and how reliable is the payout?
**Dividend payment:** No current dividend payment (2025)
LigaChem Biosciences Inc. (KOSDAQ:A141080) has not paid any dividends in recent years. The company is heavily focused on research and development, which is typical for companies in the biotechnology industry. This strategy allows them to inve...
